Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis

We have previously shown that high expression of prolactin-induced protein (PIP) correlates with the response of breast cancer (BC) patients to standard adjuvant chemotherapy (doxorubicin and cyclophosphamide), which suggests that the absence of this glycoprotein is associated with resistance of tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbaniak, Anna, Jablonska, Karolina, Suchanski, Jaroslaw, Partynska, Aleksandra, Szymczak-Kulus, Katarzyna, Matkowski, Rafal, Maciejczyk, Adam, Ugorski, Maciej, Dziegiel, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121699/
https://www.ncbi.nlm.nih.gov/pubmed/37085653
http://dx.doi.org/10.1038/s41598-023-33707-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121699/
https://www.ncbi.nlm.nih.gov/pubmed/37085653
http://dx.doi.org/10.1038/s41598-023-33707-w

Ejemplares similares